SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

DataMEDS AI Agrees to Acquire TBIA Cancer AI Blood Test Platform

DataMEDS AI agreed to acquire the TBIA cancer AI blood test platform from the Todos Medical estate for its subsidiary Helomics, Inc.

MEDS

Related stories